PRESS RELEASE published on 01/29/2025 at 12:30, 10 months 7 days ago NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025 NanoViricides, Inc. presents its groundbreaking broad-spectrum antiviral drug NV-387 at MicroCap Conference 2025, showing promising results against various viral infections NanoViricides NV-387 Microcap Conference Antiviral Drug Viral Infections
BRIEF published on 01/27/2025 at 12:35, 10 months 9 days ago NanoViricides Advances NV-387 to Phase II Clinical Trial NanoViricides NV-387 Clinical Trial Antiviral Drug MPOX Treatment
BRIEF published on 01/27/2025 at 12:35, 10 months 9 days ago NanoViricides fait passer le NV-387 à l'essai clinique de phase II NanoViricides NV-387 Essai Clinique Médicament Antiviral Traitement MPox
PRESS RELEASE published on 01/27/2025 at 12:30, 10 months 9 days ago NanoViricides Engages CRO for Phase II Clinical Trial NanoViricides, Inc. engages a Clinical Research Organization for Phase II trial of broad-spectrum antiviral drug NV-387 targeting MPox virus infection. Drug aims to combat viral diseases effectively NanoViricides NV-387 Clinical Trial Antiviral Drug Mpox Virus
BRIEF published on 01/13/2025 at 12:35, 10 months 23 days ago NanoViricides to Present Breakthrough Antiviral Developments at Biotech Showcase NanoViricides NV-387 Biotech Showcase Clinical Trials Antiviral Drugs
BRIEF published on 01/13/2025 at 12:35, 10 months 23 days ago NanoViricides présentera ses avancées antivirales révolutionnaires au Biotech Showcase NanoViricides NV-387 Essais Cliniques Médicaments Antiviraux Vitrine Biotechnologique
PRESS RELEASE published on 01/13/2025 at 12:30, 10 months 23 days ago NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025 NanoViricides, Inc. to present Phase II-ready drug NV-387 at Biotech Showcase 2025 in San Francisco, demonstrating broad-spectrum antiviral activity against various infections NV-387 NanoViricides Inc. Antiviral Drug San Francisco Biotech Showcase 2025
BRIEF published on 01/08/2025 at 12:35, 10 months 28 days ago Broad-Spectrum Antivirals: A Necessity Amid Multiple Viral Threats NanoViricides NV-387 Broad-spectrum Antivirals RNA Viruses Viral Resistance
BRIEF published on 01/08/2025 at 12:35, 10 months 28 days ago Antiviraux à large spectre : une nécessité face aux multiples menaces virales NanoViricides NV-387 Antiviraux À Large Spectre Virus À ARN Résistance Virale
PRESS RELEASE published on 01/08/2025 at 12:30, 10 months 28 days ago Multiple Viral Threats Amplify Call for Preparedness with Broad-Spectrum Antivirals NanoViricides, Inc. President Dr. Anil Diwan comments on multiple pandemic-causing viruses worldwide, highlighting NV-387's broad-spectrum antiviral capabilities NanoViricides NV-387 Antiviral Broad-spectrum Pandemic
Published on 12/06/2025 at 02:00, 12 minutes ago Northern Dynasty Provides Update on Board Search and Audit & Risk Committee Composition
Published on 12/06/2025 at 01:15, 57 minutes ago Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
Published on 12/06/2025 at 00:25, 1 hour 47 minutes ago GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 2 hours 12 minutes ago Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 2 hours 42 minutes ago 55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 22:15, 3 hours 56 minutes ago CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 4 hours ago EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 7 hours 14 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 7 hours 57 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 23:00, 3 hours 12 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 3 hours 12 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 3 hours 12 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 3 hours 12 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 8 hours 54 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
